Css LLC Alnylam Pharmaceuticals, Inc. Call Options Transaction History

Css LLC

  • $1.01 Billion
  • Q2 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$143.31 - $247.0 $71,655 - $123,500
500 New
500 $121,000
Q2 2022

Aug 15, 2022
BUY
$120.42 - $169.29 $602,100 - $846,450
5,000 New
5,000 $729,000
Q1 2022

May 16, 2022
SELL
$127.18 - $173.91 $635,900 - $869,550
-5,000 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$159.56 - $209.29 $797,800 - $1.05 Million
5,000 New
5,000 $848,000

Others Institutions Holding ALNY

# of Institutions
655
Shares Held
109M
Call Options Held
2.13M
Put Options Held
1.99M
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $33.1B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Css LLC Portfolio

Follow Css LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

News

Stay updated on Css LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email